Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2017

Planlagt Fastgjort Låst Flyttet Genmab
1.9k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #823

    OK, havde overset det - vi har ikke SB i Zambia

    1 Reply Last reply
    0
    • P Offline
      P Offline
      Plimsoller
      wrote on sidst redigeret af
      #824

      Så må I tænke jer til hvederne:-)

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #825

        positive results for durvalumab in non-small cell lung cancer , AstraZeneca +5%
        https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2017/imfinzi-significantly-reduces-the-risk-of-disease-worsening-or-death-in-the-phase-iii-pacific-trial-for-stage-iii-unresectable-lung-cancer-12052017.html

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #826

          Er durvalumab et Genmab produkt som de samarbejder med AZ om ?

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #827

            Eller er AZ ved at 'overhale' genmab

            1 Reply Last reply
            0
            • StockBullS Offline
              StockBullS Offline
              StockBull
              wrote on sidst redigeret af
              #828

              Ekker kan man forestille sig durvalumab kan virke bedre i kombination med darzalex

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #829

                Det sidste 😉

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #830

                  Hellere en åben børs end varme hveder. 🙂

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    bibob
                    wrote on sidst redigeret af
                    #831

                    StockBull. - https://www.clinicaltrials.gov/ct2/results?term=Daratumumab+-+durvalumab&Search=Search

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #832

                      I NSCLC er dara i et kombiforsøg med atezolizumab, som også er en PD-L1-blokker. https://www.clinicaltrials.gov/ct2/show/NCT03023423?term=luc2001&rank=3

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #833

                        Men AZ er pænt langt fremme med dette fase 3 forsøg.

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #834

                          As long as they combine well with Dara, i dont really care which PD-L1 blokker is used... 😉 I even think the more (good) choices, the better, in order to reach as many patie
                          nts as possible?

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #835

                            Keytruda er lang fremme https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm558048.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              GeorgeBest
                              wrote on sidst redigeret af
                              #836

                              Dara + Opdivo testes også i NSCLC. se side 9 i vedlagte http://files.shareholder.com/downloads/AMDA-KPIBN/138540251x7895654x942273/927E2A2C-FE48-411B-8753-CB30A0B296E1/Q1_2017_Interim_Report_final.pdf

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #837

                                each time i look at the Arzerra royalty of 20%, i have to think of that rumour that the original JNJ deal on Dara also started at 20%....

                                1 Reply Last reply
                                0
                                • H Offline
                                  H Offline
                                  Hamming
                                  wrote on sidst redigeret af
                                  #838

                                  I går linkede jeg til et studie med JNJ-64007957. Jeg går ud fra, at der er tale om et nyt stof i duobody-samarbejdet med jnj. Hvornår falder der milestones i disse aftaler?

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #839

                                    Hamming der har været linket til studiet før. Der falder sikkert en milestone når første patient indrulles !

                                    1 Reply Last reply
                                    0
                                    • H Offline
                                      H Offline
                                      Hamming
                                      wrote on sidst redigeret af
                                      #840

                                      Fornemt

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #841

                                        Vi kan også forvente en milestone, når Teprotumumab går i ph3

                                        1 Reply Last reply
                                        0
                                        • U Offline
                                          U Offline
                                          Unginvestor
                                          wrote on sidst redigeret af
                                          #842

                                          Hej alle. Nu hvor markedet er lukket, kan vi jo bruge tiden på noget lidt andet 🙂 Jeg skal skrive en skoleopgave om en valgfri virksomhed. Det blev selvfølgelig Genmab.. Kan i give mig navne og tal på Genmabs største aktionærer? På forhånd tak 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger